FDA GCP Inspection Trends Identified Using AI

Presented Tuesday, June 14, 2022

Download this informative 1-hour presentation with insights into FDA GCP inspection trends, including intelligence on data integrity and clinical investigator enforcement activity. 

What will be covered:
  • Importance and challenges of human clinical studies¬†
  • Data sources and evaluation using AI Tools
  • What we can learn from US FDA Inspections of Clinical Investigators
  • A deeper dive into FDA Warning Letters and 483 data with some surprises

If you have any questions or comments, please do not hesitate to contact someone on our team at info@redica.com or +1 (844) 332-3320.